 | • レポートコード：MRC2102QY15840 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のワクチン市場について種類別（組換えワクチン、ウイルスワクチン、多糖類ワクチン、その他）、用途別（コレラ、B型肝炎、ジフテリア、破傷風、麻疹ワクチン、A型肝炎、弱毒生インフルエンザワクチン、ポリオワクチン、狂犬病ワクチン）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ワクチン市場の概要 ・世界の主要地域別ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のワクチン市場規模2015-2026：種類別（組換えワクチン、ウイルスワクチン、多糖類ワクチン、その他） ・世界のワクチン市場規模2015-2026：用途別（コレラ、B型肝炎、ジフテリア、破傷風、麻疹ワクチン、A型肝炎、弱毒生インフルエンザワクチン、ポリオワクチン、狂犬病ワクチン） ・ワクチンの米国市場規模2015-2020 ・ワクチンのヨーロッパ市場規模2015-2020 ・ワクチンの中国市場規模2015-2020 ・ワクチンの日本市場規模2015-2020 ・ワクチンの東南アジア市場規模2015-2020 ・ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ワクチンの市場動向・機会・課題 ・調査の結論 |
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as foreign, destroy it, and “remember” it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Vaccines can be divided into recombinant vaccines, viral vaccines, polysaccharide vaccines and others. Recombinant vaccines and viral vaccines contain many kinds of vaccines, and the demand is larger than others kinds. But with the development of new technologies, more and more new types of vaccines will be popularized. The scope for disease prevention will be enlarged .The demand of other kinds is also increasing.
Market Analysis and Insights: Global Vaccines Market
The global Vaccines market size is projected to reach US$ 58340 million by 2026, from US$ 42070 million in 2020, at a CAGR of 5.6% during 2021-2026.
Global Vaccines Scope and Market Size
The global Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Vaccines market is segmented into
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segment by Application, the Vaccines market is segmented into
Cholera
Hepatitis B
Diphtheria
Tetanus
Measles vaccine
Hepatitis A
Live attenuated influenza vaccine
Polio vaccine
Rabies vaccine
The Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vaccines Market Share Analysis
Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vaccines business, the date to enter into the Vaccines market, Vaccines product introduction, recent developments, etc.
The major vendors covered:
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
1 Vaccines Market Overview
1.1 Vaccines Product Scope
1.2 Vaccines Segment by Type
1.2.1 Global Vaccines Sales by Type (2020-2026)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines Segment by Application
1.3.1 Global Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Cholera
1.3.3 Hepatitis B
1.3.4 Diphtheria
1.3.5 Tetanus
1.3.6 Measles vaccine
1.3.7 Hepatitis A
1.3.8 Live attenuated influenza vaccine
1.3.9 Polio vaccine
1.3.10 Rabies vaccine
1.4 Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Vaccines Price Trends (2015-2026)
2 Vaccines Estimate and Forecast by Region
2.1 Global Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Vaccines Estimates and Projections (2015-2026)
2.4.3 China Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Vaccines Estimates and Projections (2015-2026)
2.4.6 India Vaccines Estimates and Projections (2015-2026)
3 Global Vaccines Competition Landscape by Players
3.1 Global Top Vaccines Players by Sales (2015-2020)
3.2 Global Top Vaccines Players by Revenue (2015-2020)
3.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines as of 2019)
3.4 Global Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Vaccines Players (Opinion Leaders)
4 Global Vaccines Market Size by Type
4.1 Global Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Vaccines Price by Type (2015-2020)
4.2 Global Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Vaccines Price Forecast by Type (2021-2026)
5 Global Vaccines Market Size by Application
5.1 Global Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Vaccines Price by Application (2015-2020)
5.2 Global Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Vaccines Price Forecast by Application (2021-2026)
6 United States Vaccines Market Facts & Figures
6.1 United States Vaccines Sales Market Share by Company (2015-2020)
6.2 United States Vaccines Sales Market Share by Type (2015-2020)
6.3 United States Vaccines Sales Market Share by Application (2015-2020)
7 Europe Vaccines Market Facts & Figures
7.1 Europe Vaccines Sales Market Share by Company (2015-2020)
7.2 Europe Vaccines Sales Market Share by Type (2015-2020)
7.3 Europe Vaccines Sales Market Share by Application (2015-2020)
8 China Vaccines Market Facts & Figures
8.1 China Vaccines Sales Market Share by Company (2015-2020)
8.2 China Vaccines Sales Market Share by Type (2015-2020)
8.3 China Vaccines Sales Market Share by Application (2015-2020)
9 Japan Vaccines Market Facts & Figures
9.1 Japan Vaccines Sales Market Share by Company (3015-3030)
9.2 Japan Vaccines Sales Market Share by Type (2015-2020)
9.3 Japan Vaccines Sales Market Share by Application (2015-2020)
10 Southeast Asia Vaccines Market Facts & Figures
10.1 Southeast Asia Vaccines Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Vaccines Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Vaccines Sales Market Share by Application (2015-2020)
11 India Vaccines Market Facts & Figures
11.1 India Vaccines Sales Market Share by Company (2015-2020)
11.2 India Vaccines Sales Market Share by Type (2015-2020)
11.3 India Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Vaccines Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Vaccines Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Business Overview
12.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Vaccines Products Offered
12.2.5 Sanofi Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Vaccines Products Offered
12.4.5 Pfizer Recent Development
12.5 Novartis(GSK)
12.5.1 Novartis(GSK) Corporation Information
12.5.2 Novartis(GSK) Business Overview
12.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis(GSK) Vaccines Products Offered
12.5.5 Novartis(GSK) Recent Development
12.6 CSL
12.6.1 CSL Corporation Information
12.6.2 CSL Business Overview
12.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 CSL Vaccines Products Offered
12.6.5 CSL Recent Development
12.7 MedImmune LLC
12.7.1 MedImmune LLC Corporation Information
12.7.2 MedImmune LLC Business Overview
12.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 MedImmune LLC Vaccines Products Offered
12.7.5 MedImmune LLC Recent Development
12.8 J&J(Crucell)
12.8.1 J&J(Crucell) Corporation Information
12.8.2 J&J(Crucell) Business Overview
12.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 J&J(Crucell) Vaccines Products Offered
12.8.5 J&J(Crucell) Recent Development
12.9 China National Biotec
12.9.1 China National Biotec Corporation Information
12.9.2 China National Biotec Business Overview
12.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 China National Biotec Vaccines Products Offered
12.9.5 China National Biotec Recent Development
12.10 Tiantan
12.10.1 Tiantan Corporation Information
12.10.2 Tiantan Business Overview
12.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Tiantan Vaccines Products Offered
12.10.5 Tiantan Recent Development
12.11 Hualan
12.11.1 Hualan Corporation Information
12.11.2 Hualan Business Overview
12.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hualan Vaccines Products Offered
12.11.5 Hualan Recent Development
12.12 Kangtai
12.12.1 Kangtai Corporation Information
12.12.2 Kangtai Business Overview
12.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Kangtai Vaccines Products Offered
12.12.5 Kangtai Recent Development
12.13 Hissen
12.13.1 Hissen Corporation Information
12.13.2 Hissen Business Overview
12.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hissen Vaccines Products Offered
12.13.5 Hissen Recent Development
12.14 Jintan
12.14.1 Jintan Corporation Information
12.14.2 Jintan Business Overview
12.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Jintan Vaccines Products Offered
12.14.5 Jintan Recent Development
13 Vaccines Manufacturing Cost Analysis
13.1 Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Vaccines
13.4 Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Vaccines Distributors List
14.3 Vaccines Customers
15 Market Dynamics
15.1 Vaccines Market Trends
15.2 Vaccines Opportunities and Drivers
15.3 Vaccines Market Challenges
15.4 Vaccines Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Vaccines Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Vaccines Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Vaccines Sales (K Pcs) by Region (2015-2020)
Table 5. Global Vaccines Sales Market Share by Region (2015-2020)
Table 6. Global Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Vaccines Revenue Share by Region (2015-2020)
Table 8. Global Vaccines Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Vaccines Revenue Share Forecast by Region (2021-2026)
Table 12. Global Vaccines (K Pcs) of Key Companies (2015-2020)
Table 13. Global Vaccines Sales Share by Company (2015-2020)
Table 14. Global Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Vaccines Revenue Share by Company (2015-2020)
Table 16. Global Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines as of 2019)
Table 17. Global Vaccines Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Vaccines Players
Table 22. Global Vaccines Sales (K Pcs) by Type (2015-2020)
Table 23. Global Vaccines Sales Share by Type (2015-2020)
Table 24. Global Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Vaccines Price (K Pcs) by Type (2015-2020)
Table 26. Global Vaccines Sales Share by Type (2021-2026)
Table 27. Global Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Vaccines Revenue Share by Type (2021-2026)
Table 29. Global Vaccines Price (K Pcs) by Type (2021-2026)
Table 30. Global Vaccines Sales (K Pcs) by Application (2015-2020)
Table 31. Global Vaccines Sales Share by Application (2015-2020)
Table 32. Global Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Vaccines Price (K Pcs) by Application (2015-2020)
Table 34. Global Vaccines Sales (K Pcs) by Application (2021-2026)
Table 35. Global Vaccines Sales Share by Application (2021-2026)
Table 36. Global Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Vaccines Revenue Share by Application (2021-2026)
Table 38. Global Vaccines Price (K Pcs) by Application (2021-2026)
Table 39. United States Vaccines Sales (K Pcs) by Company (2015-2020)
Table 40. United States Vaccines Sales Market Share by Company (2015-2020)
Table 41. United States Vaccines Sales (K Pcs) by Type (2015-2020)
Table 42. United States Vaccines Sales Market Share by Type (2015-2020)
Table 43. United States Vaccines Sales (K Pcs) by Application (2015-2020)
Table 44. United States Vaccines Sales Market Share by Application (2015-2020)
Table 45. Europe Vaccines Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Vaccines Sales Market Share by Company (2015-2020)
Table 47. Europe Vaccines Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Vaccines Sales Market Share by Type (2015-2020)
Table 49. Europe Vaccines Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Vaccines Sales Market Share by Type (2015-2020)
Table 51. China Vaccines Sales (K Pcs) by Company (2015-2020)
Table 52. China Vaccines Sales Market Share by Company (2015-2020)
Table 53. China Vaccines Sales (K Pcs) by Type (2015-2020)
Table 54. China Vaccines Sales Market Share by Type (2015-2020)
Table 55. China Vaccines Sales (K Pcs) by Application (2015-2020)
Table 56. China Vaccines Sales Market Share by Application (2015-2020)
Table 57. Japan Vaccines Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Vaccines Sales Market Share by Company (2015-2020)
Table 59. Japan Vaccines Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Vaccines Sales Market Share by Type (2015-2020)
Table 61. Japan Vaccines Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Vaccines Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Vaccines Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Vaccines Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Vaccines Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Vaccines Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Vaccines Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Vaccines Sales Market Share by Application (2015-2020)
Table 69. India Vaccines Sales (K Pcs) by Company (2015-2020)
Table 70. India Vaccines Sales Market Share by Company (2015-2020)
Table 71. India Vaccines Sales (K Pcs) by Type (2015-2020)
Table 72. India Vaccines Sales Market Share by Type (2015-2020)
Table 73. India Vaccines Sales (K Pcs) by Application (2015-2020)
Table 74. India Vaccines Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. GSK Vaccines Product
Table 79. GSK Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Sanofi Vaccines Product
Table 84. Sanofi Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Merck Vaccines Product
Table 89. Merck Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Pfizer Vaccines Product
Table 94. Pfizer Recent Development
Table 95. Novartis(GSK) Corporation Information
Table 96. Novartis(GSK) Description and Business Overview
Table 97. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Novartis(GSK) Vaccines Product
Table 99. Novartis(GSK) Recent Development
Table 100. CSL Corporation Information
Table 101. CSL Description and Business Overview
Table 102. CSL Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. CSL Vaccines Product
Table 104. CSL Recent Development
Table 105. MedImmune LLC Corporation Information
Table 106. MedImmune LLC Description and Business Overview
Table 107. MedImmune LLC Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. MedImmune LLC Vaccines Product
Table 109. MedImmune LLC Recent Development
Table 110. J&J(Crucell) Corporation Information
Table 111. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. J&J(Crucell) Description and Business Overview
Table 113. J&J(Crucell) Vaccines Product
Table 114. J&J(Crucell) Recent Development
Table 115. China National Biotec Corporation Information
Table 116. China National Biotec Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. China National Biotec Description and Business Overview
Table 118. China National Biotec Vaccines Product
Table 119. China National Biotec Recent Development
Table 120. Tiantan Corporation Information
Table 121. Tiantan Description and Business Overview
Table 122. Tiantan Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Tiantan Vaccines Product
Table 124. Tiantan Recent Development
Table 125. Hualan Corporation Information
Table 126. Hualan Description and Business Overview
Table 127. Hualan Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Hualan Vaccines Product
Table 129. Hualan Recent Development
Table 130. Kangtai Corporation Information
Table 131. Kangtai Description and Business Overview
Table 132. Kangtai Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Kangtai Vaccines Product
Table 134. Kangtai Recent Development
Table 135. Hissen Corporation Information
Table 136. Hissen Description and Business Overview
Table 137. Hissen Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Hissen Vaccines Product
Table 139. Hissen Recent Development
Table 140. Jintan Corporation Information
Table 141. Jintan Description and Business Overview
Table 142. Jintan Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Jintan Vaccines Product
Table 144. Jintan Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Vaccines Distributors List
Table 148. Vaccines Customers List
Table 149. Vaccines Market Key Trends
Table 150. Vaccines Key Opportunities and Drivers
Table 151. Vaccines Market Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines Product Picture
Figure 2. Global Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Vaccines Market Share by Application in 2020 & 2026
Figure 6. Cholera Examples
Figure 7. Hepatitis B Examples
Figure 8. Diphtheria Examples
Figure 9. Tetanus Examples
Figure 10. Measles vaccine Examples
Figure 11. Hepatitis A Examples
Figure 12. Live attenuated influenza vaccine Examples
Figure 13. Polio vaccine Examples
Figure 14. Rabies vaccine Examples
Figure 15. Global Vaccines Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Global Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 17. Global Vaccines Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 18. Global Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 19. Global Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 20. United States Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. United States Vaccines Sales (K Pcs) Growth Rate (2015-2026)
Figure 22. Europe Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Europe Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 24. China Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. China Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 26. Japan Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Japan Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Southeast Asia Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. Southeast Asia Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 30. India Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 31. India Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 32. Global 5 Largest Vaccines Players Market Share by Revenue in Vaccines 2015 & 2019
Figure 33. Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 34. Global Vaccines Revenue Share by Type (2015-2020)
Figure 35. Global Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 36. Global Vaccines Revenue Share by Application (2015-2020)
Figure 37. Global Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 38. United States Vaccines Sales Market Share by Type in 2019
Figure 39. United States Vaccines Sales Market Share by Type in 2019
Figure 40. Europe Vaccines Sales Market Share by Company in 2019
Figure 41. Europe Vaccines Sales Market Share by Type in 2019
Figure 42. Europe Vaccines Sales Market Share by Application in 2019
Figure 43. China Vaccines Sales Market Share by Company in 2019
Figure 44. China Vaccines Sales Market Share by Type in 2019
Figure 45. China Vaccines Sales Market Share by Application in 2019
Figure 46. Japan Vaccines Sales Market Share by Company in 2019
Figure 47. Japan Vaccines Sales Market Share by Type in 2019
Figure 48. Japan Vaccines Sales Market Share by Application in 2019
Figure 49. Southeast Asia Vaccines Sales Market Share by Company in 2019
Figure 50. Southeast Asia Vaccines Sales Market Share by Type in 2019
Figure 51. Southeast Asia Vaccines Sales Market Share by Application in 2019
Figure 52. India Vaccines Sales Market Share by Company in 2019
Figure 53. India Vaccines Sales Market Share by Type in 2019
Figure 54. India Vaccines Sales Market Share by Application in 2019
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Vaccines
Figure 57. Manufacturing Process Analysis of Vaccines
Figure 58. Vaccines Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
ウイルスワクチンの世界市場レポート2020 Market Analysis and Insights: Global Viral Vaccines Market The global Viral Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Viral Vaccines Scope and Market Size The global Viral Vaccines market is segmented by …- トラベラーズワクチンの世界市場レポート2020 A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates …
- DNAワクチンの世界市場レポート2020 The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines. N…
- ジカウイルスワクチンの世界市場レポート2020 Market Analysis and Insights: Global Zika Virus Vaccines Market The global Zika Virus Vaccines market size is projected to reach US$ 16010 million by 2026, from US$ 13450 million in 2020, at a CAGR of 2.9% during 2021-2026. Global Zika Virus Vaccines Scope and Market Size The global Zika Virus Vacci…
- 豚用ワクチンの世界市場レポート2020 The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination. Vaccines contain antigens from vi…